As the name suggests, peptide stacking involves combining multiple amino acid-based supplements to amplify their effects, ...

A longevity expert reveals how immune systems begin aging after 35, making people more susceptible to infections and immune-related disorders over time.

Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study Efdoralprin alfa demonstrated superiority in a head-to-head study versus ...

Sanofi’s $1.7 billion rare disease bet from last year has delivered a phase 2 win. In a midstage study, efdoralprin alfa beat the standard of care on primary and key secondary endpoints, positioning ...

When a disease runs in your family, you don’t learn about it from textbooks. You learn about it at funerals, in hospital beds, and emergency rooms. My family has lost multiple members to Alpha-1 ...